T se Ping, also known by her Chinese name Zheng Xiangling, is a Chinese pharmaceutical billionaire. Her fortune is derived from her family's massive stake in Sino Biopharmaceutical, one of China's largest and most successful drugmakers. She is the wife of Dhanin Chearavanont, the senior chairman of Thailand's Charoen Pokphand (CP) Group, one of Asia's most powerful conglomerates. Dhanin was the founder of Sino Biopharmaceutical, and the company has been run by their children.
Tse Ping serves as an executive director and vice chairwoman of the company. Her four children—two sons and two daughters—are all senior executives at the firm. The company has a strong focus on developing and marketing treatments for liver diseases, particularly hepatitis, which is a major health concern in China. The family's combined stake in the Hong Kong-listed pharmaceutical giant is the source of their immense, multi-billion dollar fortune, making them one of the wealthiest families in the global healthcare industry.
Advertisement
Tse Ping is a Hong Kong businessman, the self-made billionaire Founder and former Chairman of Sino Biopharmaceutical Ltd. (HKSE: 1177), a major global manufacturer of generic and proprietary pharmaceutical products. His career is rooted in pharmaceuticals, R&D, and entrepreneurial audacity.
Tse's philosophical approach centers on scale, technological excellence, and long-term commitment to affordable healthcare (pioneering the modern private pharmaceutical model). He founded Sino Biopharmaceutical in 1997, recognizing the immense, untapped domestic and international demand for high-quality, cost-effective drugs.
Tse Ping's strategic genius was his commitment to R&D and scale. He founded Sino Biopharmaceutical in 1997, successfully building it into a global force by focusing on proprietary and generic drug manufacturing. His structural contribution is immense: pioneering the modern, scale pharmaceutical innovation model in China, providing essential medicines. The company successfully executed its IPO on the HKSE.
He retired as Chairman in 2020, transitioning the role to his daughter, Theresa Tse. His wealth is secured by the colossal, long-term, stable profitability of the global pharmaceutical and healthcare sector.
Advertisement
Founds Sino Biopharmaceutical Ltd. (Founding).
Sino Biopharmaceutical executes its successful IPO on the HKSE (Financial Milestone).
Steps down as Chairman, transitioning the role to his daughter, Theresa Tse (Executive Transition).
Continues as Founder and major shareholder, guiding the global pharmaceutical giant (Executive Oversight).
Tse Ping's wealth is concentrated in his founding equity and continued executive leadership of the publicly traded pharmaceutical giant, Sino Biopharmaceutical Ltd. (HKSE: 1177), and his private investments.
Advertisement
Tse Ping's social impact stems from Sino Biopharmaceutical's role in providing essential and affordable medicines, particularly for chronic diseases, improving healthcare access for millions of patients in China and internationally. The company actively supports educational and medical research initiatives through its foundations.
His personal philanthropy supports various community and educational initiatives.
Tse Ping maintains the professional, composed style of a corporate executive. His attire is consistently formal and high-quality, favoring tailored business suits. His aesthetic reflects serious authority and stability, typical of a leader in the specialized pharmaceutical sector.
Residing in Hong Kong, his luxury is the immense security and financial reward derived from his multi-billion dollar fortune. His life is dedicated to industrial scale, technological innovation, and corporate governance.
Advertisement
No publicly available quotes.
Advertisement
-0.02% | -$0.35M
+50.26% | +$735.14M
This profile is compiled from verified biographical and financial records:
All information is cross-referenced with public sources for accuracy; some narrative sections are AI-assisted summaries.
If you find any inaccuracies, please report them to admin@redcarpetlife.in
Sponsored Content